PPI-Clopidogrel Shows Benefit, But Omeprazole Concern Remains - Study
This article was originally published in The Tan Sheet
Executive Summary
An analysis shows a benefit from using proton pump inhibitors with clopidogrel compared with using the antiplatelet drug alone, but reinforces concerns that the PPI omeprazole diminishes the efficacy of the blood thinner
You may also be interested in...
Public Citizen Urges FDA To Add Sweeping Warnings To PPI Labels
Public Citizen petitions FDA to add several warnings to all proton pump inhibitors, including OTCs – which the agency previously determined do not pose the same level of risk as prescription versions.
Regulatory News In Brief
OTC PPIs add blood-thinner advisory
Research & Development In Brief
Report addresses PPIs, antiplatelet therapy